Diagnostic Value of Serum Levels of IL-22, IL-23, and IL-17 for Idiopathic Pulmonary Fibrosis Associated with Lung Cancer

Figures & data

Table 1 Clinical Information of the Patients

	Number	IPF		p value
		Yes (n=59)	No (n=56)
Gender
Male	69	39	30	0.1704
Female	46	20	26
Ages
≤65	40	21	19	0.8514
>65	75	38	37
Metastasis
Yes	46	24	22	0.8789
No	69	35	34
TNM stage
I-II	35	12	23	0.0157**
III-IV	80	47	33
Degree of differentiation
Well-Moderate	52	31	25	0.3969
Poor	63	28	31
Smoking history
Yes	78	42	36	0.4285
No	37	17	20

Note: ** p<0.01.

Figure 1 Comparison of the levels of IL-17 between control, lung cancer patients and lung cancer-associated IPF. ** P<0.01, *** P<0.001.

Figure 2 Comparison of the levels of IL-22 between control, lung cancer patients and lung cancer-associated IPF. *P<0.05, *** P<0.001.

Figure 3 Comparison of the levels of IL-23 between control, lung cancer patients and lung cancer associated IPF. ** P<0.01, *** P<0.001.

Figure 4 ROC of IL-17.

Figure 5 ROC of IL-22.

Figure 6 ROC of IL-23.